{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:54:09Z","timestamp":1793879649228,"version":"4.7.0"},"reference-count":23,"publisher":"Ubiquity Press, Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["FS\/18\/21\/33447"],"award-info":[{"award-number":["FS\/18\/21\/33447"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,20]]},"DOI":"10.5334\/gh.1275","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T06:42:33Z","timestamp":1700462553000},"source":"Crossref","is-referenced-by-count":3,"title":["Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.5334","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9233-9831","authenticated-orcid":false,"given":"Marianna","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-0825","authenticated-orcid":false,"given":"Aldostefano","family":"Porcari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6983-9598","authenticated-orcid":false,"given":"Philip N.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"key":"key20231120064225_B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2020.09.025","article-title":"Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery","volume":"82","year":"2020","journal-title":"European Journal Internal Medicine"},{"key":"key20231120064225_B2","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review","volume":"79","year":"2022","journal-title":"Journal American College Cardiology"},{"key":"key20231120064225_B3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","year":"2023","journal-title":"European Journal Heart Failure"},{"key":"key20231120064225_B4","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/ejhf.2646","article-title":"Sex differences among patients with transthyretin amyloid cardiomyopathy \u2013 from diagnosis to prognosis","volume":"24","year":"2022","journal-title":"European Journal Heart Failure"},{"key":"key20231120064225_B5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ejhf.2606","article-title":"Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis","volume":"24","year":"2022","journal-title":"European Journal Heart Failure"},{"key":"key20231120064225_B6","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1093\/cvr\/cvac119","article-title":"Transthyretin cardiac amyloidosis","volume":"118","year":"2023","journal-title":"Cardiovascular Research"},{"key":"key20231120064225_B7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles","volume":"12","year":"2019","journal-title":"JACC Cardiovascular Imaging"},{"key":"key20231120064225_B8","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years","volume":"146","year":"2022","journal-title":"Circulation"},{"key":"key20231120064225_B9","first-page":"11","article-title":"Cardiac amyloidosis: the great pretender","volume":"20","year":"2015","journal-title":"Heart Fail Rev"},{"key":"key20231120064225_B10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ehf2.13606","article-title":"Prognostic significance of unexplained left ventricular hypertrophy in patients undergoing carpal tunnel surgery","volume":"9","year":"2022","journal-title":"ESC Heart Failure"},{"key":"key20231120064225_B11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","year":"2020","journal-title":"European Journal Heart Failure"},{"key":"key20231120064225_B12","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","year":"2021","journal-title":"European Heart Journal"},{"key":"key20231120064225_B13","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"key20231120064225_B14","first-page":"e4","article-title":"Comparison of different technetium-99 m-labelled bone tracers for imaging cardiac amyloidosis","volume":"30","year":"2022","journal-title":"European Journal Preventive Cardiology"},{"key":"key20231120064225_B15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","year":"2018","journal-title":"New England Journal Medicine"},{"key":"key20231120064225_B16","unstructured":"https:\/\/www.acc.org\/Latest-in-Cardiology\/Clinical-Trials\/2023\/08\/24\/02\/29\/attribute-cm."},{"key":"key20231120064225_B17","first-page":"438","article-title":"Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis","volume":"4","year":"2019","journal-title":"Translational Science"},{"key":"key20231120064225_B18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression","volume":"14","year":"2021","journal-title":"JACC Cardiovascular Imaging"},{"key":"key20231120064225_B19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","year":"2021","journal-title":"New England Journal Medicine"},{"key":"key20231120064225_B20","article-title":"ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer\u2019s disease","volume":"9","year":"2023","journal-title":"Alzheimer\u2019s Dementia"},{"key":"key20231120064225_B21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2303765","article-title":"Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid","volume":"389","year":"2023","journal-title":"New England Journal Medicine"},{"key":"key20231120064225_B22","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMc2304584","article-title":"Antibody-Associated Reversal of ATTR Amyloidosis\u2013Related Cardiomyopathy","volume":"388","year":"2023","journal-title":"New England Journal Medicine"},{"issue":"45","key":"key20231120064225_B23","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","year":"2022","journal-title":"European Heart Journal"}],"container-title":["Global Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-gh-files\/journals\/1\/articles\/1275\/655b46156639c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:43:54Z","timestamp":1782816234000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.1275\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,11,20]]}},"alternative-id":["10.5334\/gh.1275"],"URL":"https:\/\/doi.org\/10.5334\/gh.1275","relation":{},"ISSN":["2211-8179"],"issn-type":[{"value":"2211-8179","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"63"}}